Is a complete FLNA research report available?

No complete published report is available for Filana Therapeutics, Inc. (FLNA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Filana Therapeutics, Inc. (FLNA)

NASDAQ: FLNA · USD

$0.96

+0.09 (+10.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FLNA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	46.4M
Net income (ttm)	-42.3M
EPS (ttm)	-$0.88
Shares out	48.3M
Volume	334,734
Beta	-0.74
Price target	$6.50	+577.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -42.3M
EPS (ttm): -$0.88
Market cap: 46.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All FLNA indicators

Market & fundamental data

Available fields

190

Groups with data

Currency

USD

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001069530
Company name	Filana Therapeutics, Inc.
Country	United States
Country code	US
Cusip	14817C107
Employees	20
Employees Change	-10%
Employees Change Percent	-33.33
Enterprise value	$-36.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US14817C1071
Last refreshed	2026-07-31
Market cap	$46.4M
Market cap category	Nano-Cap
Price	$0.96
Price currency	USD
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	2834
Symbol	FLNA
Website	https://www.filanatx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-91.17%
FCF yield	-65.5%
P/B ratio	0.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-15.7M
Net Income	$-42.3M
Net Income Growth Quarters	4%
Net Income Growth Years	0%
Profit Per Employee	$-2.1M
ROA	-5.58
Roa5y	-30.81
ROCE	-72.12
ROE	-55.78
Roe5y	-40.7
ROIC	-8.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-25.77%
Cagr15y	-19.7%
Cagr1y	-56.59%
Cagr20y	-16.24%
Cagr3y	-64.22%
Cagr5y	-60.78%
EPS Growth Quarters	4
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$103.9M
Cash	$82.7M
Current Assets	$83.7M
Current Liabilities	$40.2M
Debt	$0
Equity	$63.6M
Liabilities	$40.3M
Long Term Assets	$20.2M
Long Term Liabilities	$136,000
Net Cash	$82.7M
Net Cash By Market Cap	$178
Net Cash Growth	-26.43%
Net Debt Equity	$-1.3
Tangible Book Value	$63.6M
Tangible Book Value Per Share	$1.32
WACC	0.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.08
Net Working Capital	$-39.1M
Quick ratio	2.06
Working Capital	$43.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.29%
Dividend per share	$0
Dividend Yield	0%
Last Dividend	$5.25

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-94.92%
1Y total return	-56.56%
200-day SMA	2.06
3Y total return	-95.42%
50-day SMA	1.21
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.07%
All Time High	184.6
All Time High Change	-99.48%
All Time High Date	2000-07-14
All Time Low	0.76
All Time Low Change	26.32%
All Time Low Date	2018-12-24
ATR	0.07
Beta	-0.74
Beta1y	1.67
Beta2y	1.02
Ch YTD	-51.52
High	0.96
High52	4.98
High52 Date	2025-10-16
High52ch	-80.72%
Low	0.86
Low52	0.86
Low52 Date	2026-07-29
Low52ch	12.1%
Ma50ch	-20.73%
Premarket Change Percent	-1.1
Premarket Price	$0.86
Premarket Volume	2,887
Price vs 200-day SMA	-53.42%
RSI	37.6
RSI Monthly	35.07
RSI Weekly	31.97
Sharpe ratio	-0.54x
Sortino ratio	-0.81
Total Return	-0.29%
Tr YTD	-51.52
Tr15y	-96.28%
Tr1m	-21.31%
Tr1w	2.98%
Tr3m	-33.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.23
Operating Income	$-10.7M
Price target	$6.5
Price Target Change	$577

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	47,317,521%
Float Percent	97.95%
Shares Insiders	2.05%
Shares Institutions	28.25%
Shares Out	48,307,896
Shares Qo Q	0%
Shares Yo Y	0.29%
Short Float	13.18%
Short Ratio	16.35
Short Shares	12.91

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-48.8M
Adjusted OCF	-48,220,000
Average Volume	362,994.05x
Bv Per Share	1.32
CAPEX	$-581,000
Ch10y	-94.92
Ch15y	-97.15
Ch1m	-21.31
Ch1w	2.98
Ch1y	-56.56
Ch20y	-98.32
Ch3m	-33.33
Ch3y	-95.42
Ch5y	-99.07
Ch6m	-52.94
Change	10.4%
Change From Open	11.11
Close	0.87
Days Gap	-0.64
Depreciation Amortization	984,000
Dollar Volume	321,344.6
Earnings Date	2026-07-29
Earnings Time	bmo
EBIT	$-46M
EBITDA	$-45M
EPS	$-0.88
F Score	1
FCF	$-30.4M
FCF EV Yield	83.67x
FCF Per Share	$-0.63
Financing CF	-380,000
Fiscal Year End	December
Founded	1,998
Investing CF	-581,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-29
Last Report Date	2026-06-30
Last Split Date	2017-05-10
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	1.66
Ma150ch	-42.2%
Ma20	1.06
Ma20ch	-9.69%
Net CF	-30,755,000
Next Earnings Date	2026-11-11
Open	0.86
Optionable	Yes
Position In Range	100
Ppne	20,180,000
Pre Close	0.87
Price Date	2026-07-30
Ptbv Ratio	0.73
Relative Volume	0.92x
Share Based Comp	18,426,000
Tr20y	-97.11%
Tr6m	-52.94%
Us State	Texas
Volume	334,734

Filana Therapeutics, Inc. (FLNA)

Coverage state: Market snapshot only — no published research

Generate the first FLNA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · FLNA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FLNA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FLNA

Frequently asked questions